Erowid.org: Erowid Reference 8355 : Sympathomimetic toxicity in a case of analytically confirmed recreational use of naphyrone (naphthylpyrovalerone) : Derungs A, Schietzel S, Meyer MR, Maurer HH, Krähenbühl S, Liechti ME

Erowid References Database

Derungs A, Schietzel S, Meyer MR, Maurer HH, Krähenbühl S, Liechti ME. “Sympathomimetic toxicity in a case of analytically confirmed recreational use of naphyrone (naphthylpyrovalerone)”. Clinical Toxicology. 2011. <a name="ref">Derungs A, Schietzel S, Meyer MR, Maurer HH, Krähenbühl S, Liechti ME.</a> <a href="/references/8355">"Sympathomimetic toxicity in a case of analytically confirmed recreational use of naphyrone (naphthylpyrovalerone)"</a> <i>Clinical Toxicology</i>. 2011.
Text Abstract (this page) Full Text - English (private) Show Articles by Derungs A Schietzel S Meyer MR Maurer HH Krähenbühl S Liechti ME Article IDs Erowid RefID: 8355 PubMedID: unknown Collections Hofmann Collection MDMA Collection All References	Abstract Context. Naphyrone (naphthylpyrovalerone) is a cathinone derivative and recreational drug related to mephedrone. Case. We report a 31-year-old man who ingested a dose of naphyrone (100 mg), which produced acute sympathomimetic toxicity with restlessness, insomnia, anxiety, and hallucinations lasting for 2 days. Naphyrone was detected in the patient's plasma by gas chromatography with mass spectrometry at concentrations of 0.03 and 0.02 mg/L, 40 and 60 h after drug intake, respectively. Discussion. Based on the present case report and user web-reports, as well as on the chemical structure and pharmacological characteristics, naphyrone produces stimulant-like psychotropic effects and sympathomimetic toxicity. Key Words: CNS, amphetamine, stimulant, drug abuse, pharmacokinetics
Comments and Responses to this Article #
Submit Comment

[ Cite HTML ]